Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA.
Nat Commun. 2023 Feb 14;14(1):637. doi: 10.1038/s41467-023-36119-6.
Nearly half of all pregnancies are unintended; thus, existing family planning options are inadequate. For men, the only choices are condoms and vasectomy, and most current efforts to develop new contraceptives for men impact sperm development, meaning that contraception requires months of continuous pretreatment. Here, we provide proof-of-concept for an innovative strategy for on-demand contraception, where a man would take a birth control pill shortly before sex, only as needed. Soluble adenylyl cyclase (sAC) is essential for sperm motility and maturation. We show a single dose of a safe, acutely-acting sAC inhibitor with long residence time renders male mice temporarily infertile. Mice exhibit normal mating behavior, and full fertility returns the next day. These studies define sAC inhibitors as leads for on-demand contraceptives for men, and they provide in vivo proof-of-concept for previously untested paradigms in contraception; on-demand contraception after just a single dose and pharmacological contraception for men.
近半数妊娠都是意外妊娠;因此,现有的计划生育选择是不够的。对于男性来说,唯一的选择是避孕套和输精管切除术,而目前大多数开发男性新避孕药具的努力都影响精子发育,这意味着避孕需要数月的连续预处理。在这里,我们提供了一种按需避孕创新策略的概念验证,即男性可以在性行为前不久服用避孕药,按需服用。可溶性腺苷酸环化酶(sAC)对精子运动和成熟至关重要。我们发现,单次给予安全、作用迅速且作用时间长的 sAC 抑制剂可使雄性小鼠暂时不育。小鼠表现出正常的交配行为,第二天就完全恢复生育能力。这些研究将 sAC 抑制剂定义为男性按需避孕药具的先导化合物,并为以前未在避孕领域测试过的范例提供了体内概念验证;只需单次剂量即可按需避孕,以及男性的药物避孕。